Valeant enjoys big rebound after Citigroup gives thumbs up

The price of shares in Valeant Pharmaceuticals International Inc. has surged, reversing momentum after a Citigroup Inc. research note made favorable comments about the drug company and recommended buying its debt.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.